NCT02285582View on ClinicalTrials.gov

International Rare Histiocytic Disorders Registry (IRHDR)

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2028

Conditions
Rare Histiocytic Disorders (RHDs)Erdheim-Chester Disease (ECD)Rosai-Dorfman Disease (RDD)Xanthogranuloma Family (XG)Indeterminate Dendritic Cell HistiocytosisMalignant Histiocytic Neoplasm (MHN)ALK-positive HistiocytosisMixed Histiocytosis (MXH)Multicentric Reticulohistiocytoma (MRH)Necrobiotic Xanthogranuloma (NX)
Interventions
OTHER

Registry study

No intervention.

Trial Locations (15)

3584

RECRUITING

Prinses Maxima Center, Utrecht

10022

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

15219

RECRUITING

University of Pittsburgh Medical Center, Pittsburgh

90027

RECRUITING

Children's Hospital of Los Angeles, Los Angeles

93636

RECRUITING

Valley Children's Hospital, Madera

Unknown

RECRUITING

The University of Alabama at Birmingham, Birmingham

RECRUITING

Hospital Nacional de Pediatria Garrahan, Buenos Aires

RECRUITING

University Hospital Brno, Brno

RECRUITING

Rostock University Medical Hospital, Rostock

RECRUITING

Azienda Ospedaliero-Universitaria Meyer, Florence

RECRUITING

Children's Memorial Health Institute, Warsaw

RECRUITING

Hospital Universitario Cruces, Barakaldo

02215

RECRUITING

Dana-Farber Cancer Institute, Boston

M5G 1X8

RECRUITING

The Hospital for Sick Children, Toronto

H3T 1C5

ACTIVE_NOT_RECRUITING

Centre hospitalier universitaire Sainte-Justine, Montreal

All Listed Sponsors
lead

The Hospital for Sick Children

OTHER